(1)
Mushlih, Y.; Suryoadji, K. A.; Prasetyawaty, F. Survival Rate of Gemcitabine Monotherapy After Prior Platinum-Based Chemotherapy for Metastatic Bladder Cancer. Cermin Dunia Kedokteran 2022, 49, 693-701.